In Pharma Sustainability, AstraZeneca, Johnson & Johnson Rate High
On a scale of 1 to 100, AstraZeneca and Johnson & Johnson are the only pharmaceutical companies to rate above 70 in a recent survey of sustainability practices in the sector.
Other firms scoring highly are Baxter (66) and GlaxoSmithKline, Pfizer and Schering-Plough, all three of which scored 60.
Climate Counts evaluates firms’ commitments in four areas:
- whether they have measured their carbon footprint
- if they reduced their impact on global warming
- if they have supported or blocked climate legislation or policy
- to what level they have publicly disclosed their climate actions
AstraZeneca scored highly in all sectors except for policy, in which it scored a zero out of ten.
Johnson & Johnson scored highly in all sectors except for measuring its own carbon footprint, an area in which it scored 12 out of 22.
Stay Up-to-Date On Environmental Management, Energy & Sustainability News with EL's Free Daily Newsletter
Energy Manager News
- Cooling System Eliminates Chemicals by ‘Pulsing’ the Water
- Ensuring Renewable Energy Goals Become a Reality in the Caribbean
- Dunkin’ Donuts Distributor Updates with LEDs
- Grid Forecasting Tool Combines 5 Different Models
- Verizon Introduces Smart Energy-as-a-Service
- Energy Efficiency Saves $750,000 per Year for Civic Center
- Biomass Supplements Output of Geothermal Power Plant
- Schneider Uniflair LE Room Cooling Series Receives DOE Certification for Energy Efficiency